000 | 01925 a2200457 4500 | ||
---|---|---|---|
005 | 20250517194508.0 | ||
264 | 0 | _c20181024 | |
008 | 201810s 0 0 eng d | ||
022 | _a1473-0766 | ||
024 | 7 |
_a10.1080/09513590.2018.1425989 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSeyam, Emaduldin | |
245 | 0 | 0 |
_aLaparoscopic ovarian drilling versus GnRH antagonist combined with cabergoline as a prophylaxis against the re-development of ovarian hyperstimulation syndrome. _h[electronic resource] |
260 |
_bGynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology _cJul 2018 |
||
300 |
_a616-622 p. _bdigital |
||
500 | _aPublication Type: Controlled Clinical Trial; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aCabergoline |
650 | 0 | 4 |
_aChemoprevention _xmethods |
650 | 0 | 4 |
_aClomiphene _xtherapeutic use |
650 | 0 | 4 | _aDrug Resistance |
650 | 0 | 4 |
_aErgolines _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFertilization in Vitro _xmethods |
650 | 0 | 4 |
_aGonadotropin-Releasing Hormone _xantagonists & inhibitors |
650 | 0 | 4 |
_aGynecologic Surgical Procedures _xmethods |
650 | 0 | 4 |
_aHormone Antagonists _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInfertility, Female _xtherapy |
650 | 0 | 4 |
_aLaparoscopy _xmethods |
650 | 0 | 4 |
_aOvarian Hyperstimulation Syndrome _xetiology |
650 | 0 | 4 |
_aOvary _xsurgery |
650 | 0 | 4 |
_aOvulation Induction _xadverse effects |
650 | 0 | 4 |
_aPolycystic Ovary Syndrome _xtherapy |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 |
_aSecondary Prevention _xmethods |
650 | 0 | 4 | _aTreatment Failure |
700 | 1 | _aHefzy, Enas | |
773 | 0 |
_tGynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology _gvol. 34 _gno. 7 _gp. 616-622 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1080/09513590.2018.1425989 _zAvailable from publisher's website |
999 |
_c27980249 _d27980249 |